Is the Recombinant Zoster Vaccine recommended for immunocompromised adults aged 19 and older?
If you are an immunocompromised adult aged 19 or older, the Recombinant Zoster Vaccine (RZV, brand name Shingrix) is recommended to prevent shingles (herpes zoster) and its complications. The Advisory Committee on Immunization Practices (ACIP) updated its guidelines in 2021 to include this group, based on evidence that RZV is safe and effective even when the immune system is weakened by disease or treatment 9. This recommendation covers people with conditions like rheumatoid arthritis, cancer, HIV, or those who have had an organ transplant.
What the research says
A 2024 systematic review and meta-analysis of seven randomized trials found that RZV reduced the risk of shingles by 81% in immunocompromised individuals compared to placebo (RR 0.19, 95% CI 0.09–0.44) 8. The vaccine also significantly boosted both antibody and T-cell responses one month after the final dose 8. The ACIP recommendation is based on this strong evidence, noting moderate to high vaccine efficacy and an acceptable safety profile 9. For example, in people with rheumatoid arthritis, who have a higher risk of shingles (pooled proportion 6% in one meta-analysis 1), RZV offers important protection. The vaccine is the first shingles vaccine approved for immunocompromised persons 9. While some national guidelines initially focused on adults aged 50 and older, expert reviews highlight that expanded use in immunocompromised adults aged 18 and older is being considered 10.
What to ask your doctor
- Is the Recombinant Zoster Vaccine (Shingrix) right for me given my specific medical condition and treatments?
- Should I receive the two-dose series, and what is the recommended interval between doses?
- Are there any timing considerations with my current immunosuppressive medications or recent transplants?
- What side effects should I expect, and how do they compare to the risks of getting shingles?
- Will my insurance cover the vaccine, or are there assistance programs available?
This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.